Biomarkers & Diagnostics Research
Explore genetic markers, diagnostic tools, and testing methods for precision cancer care.
đ§Ŧ TP53
Tumor suppressor gene - most commonly mutated in human cancers
đ§Ŧ KRAS
Oncogene frequently mutated in pancreatic, colorectal, and lung cancers
đ§Ŧ EGFR
Receptor tyrosine kinase - target for lung cancer therapy
đ§Ŧ HER2
Growth factor receptor overexpressed in breast and gastric cancers
đ§Ŧ BRCA1
Hereditary breast and ovarian cancer gene
đ§Ŧ BRCA2
Hereditary breast and ovarian cancer gene
đ§Ŧ PD-L1
Immune checkpoint protein - predictor for immunotherapy response
đ§Ŧ ALK
Fusion gene target in non-small cell lung cancer
đ§Ŧ ROS1
Receptor tyrosine kinase fusion in lung cancer
đ§Ŧ BRAF
Oncogene mutated in melanoma and colorectal cancer
đ§Ŧ MSI-H
DNA mismatch repair deficiency - immunotherapy biomarker
đ§Ŧ PIK3CA
Oncogene frequently mutated in breast cancer
đ§Ŧ NTRK
Fusion gene target across multiple tumor types
đ§Ŧ MET
Receptor tyrosine kinase target in lung cancer
đ§Ŧ RET
Fusion gene target in thyroid and lung cancers
đ§Ŧ Liquid Biopsies
Blood-based cancer detection and monitoring methods
đ§Ŧ ctDNA Testing
Circulating tumor DNA analysis for cancer detection
đ§Ŧ Tumor Mutation Burden
Genomic biomarker predicting immunotherapy response